The global market for Mirabegron Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Mirabegron is a beta-3 adrenergic agonist which is used to manage symptoms of overactive bladder (OAB), such as frequent urination, urgency, and urinary incontinence.

North American market for Mirabegron Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Mirabegron Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Mirabegron Drugs include Astellas Pharma, Zydus Lifesciences, Lupin Pharmaceuticals, Alkem Laboratories, Chia Tai Tianqing Pharmaceutical, Zhejiang Huayi Pharmaceutical, China Resources Pharmaceutical, Jiangxi Shanxiang Pharmaceutical, CSPC Pharmaceutical, Qilu Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mirabegron Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mirabegron Drugs.

The Mirabegron Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mirabegron Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mirabegron Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mirabegron Drugs Market Report

Report Metric	Details
Report Name	Mirabegron Drugs Market
Segment by Type	Extended-release Tablet Oral Suspension
Segment by Application	Urgency Frequent Urination Urine Leakage Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Astellas Pharma, Zydus Lifesciences, Lupin Pharmaceuticals, Alkem Laboratories, Chia Tai Tianqing Pharmaceutical, Zhejiang Huayi Pharmaceutical, China Resources Pharmaceutical, Jiangxi Shanxiang Pharmaceutical, CSPC Pharmaceutical, Qilu Pharmaceutical, Jiangsu Huayang Pharmaceutical, Sichuan Gowell Pharmaceutical, Shenzhen Main Luck Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mirabegron Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mirabegron Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Mirabegron Drugs Market report?

Ans: The main players in the Mirabegron Drugs Market are Astellas Pharma, Zydus Lifesciences, Lupin Pharmaceuticals, Alkem Laboratories, Chia Tai Tianqing Pharmaceutical, Zhejiang Huayi Pharmaceutical, China Resources Pharmaceutical, Jiangxi Shanxiang Pharmaceutical, CSPC Pharmaceutical, Qilu Pharmaceutical, Jiangsu Huayang Pharmaceutical, Sichuan Gowell Pharmaceutical, Shenzhen Main Luck Pharmaceuticals

What are the Application segmentation covered in the Mirabegron Drugs Market report?

Ans: The Applications covered in the Mirabegron Drugs Market report are Urgency, Frequent Urination, Urine Leakage, Other

What are the Type segmentation covered in the Mirabegron Drugs Market report?

Ans: The Types covered in the Mirabegron Drugs Market report are Extended-release Tablet, Oral Suspension

1 Mirabegron Drugs Market Overview

1.1 Product Definition

1.2 Mirabegron Drugs by Type

1.2.1 Global Mirabegron Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Extended-release Tablet

1.2.3 Oral Suspension

1.3 Mirabegron Drugs by Application

1.3.1 Global Mirabegron Drugs Market Value by Application (2024 VS 2031)

1.3.2 Urgency

1.3.3 Frequent Urination

1.3.4 Urine Leakage

1.3.5 Other

1.4 Global Mirabegron Drugs Market Size Estimates and Forecasts

1.4.1 Global Mirabegron Drugs Revenue 2020-2031

1.4.2 Global Mirabegron Drugs Sales 2020-2031

1.4.3 Global Mirabegron Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Mirabegron Drugs Market Competition by Manufacturers

2.1 Global Mirabegron Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Mirabegron Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Mirabegron Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Mirabegron Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Mirabegron Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Mirabegron Drugs, Product Type & Application

2.7 Global Key Manufacturers of Mirabegron Drugs, Date of Enter into This Industry

2.8 Global Mirabegron Drugs Market Competitive Situation and Trends

2.8.1 Global Mirabegron Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Mirabegron Drugs Players Market Share by Revenue

2.8.3 Global Mirabegron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Mirabegron Drugs Market Scenario by Region

3.1 Global Mirabegron Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Mirabegron Drugs Sales by Region: 2020-2031

3.2.1 Global Mirabegron Drugs Sales by Region: 2020-2025

3.2.2 Global Mirabegron Drugs Sales by Region: 2026-2031

3.3 Global Mirabegron Drugs Revenue by Region: 2020-2031

3.3.1 Global Mirabegron Drugs Revenue by Region: 2020-2025

3.3.2 Global Mirabegron Drugs Revenue by Region: 2026-2031

3.4 North America Mirabegron Drugs Market Facts & Figures by Country

3.4.1 North America Mirabegron Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Mirabegron Drugs Sales by Country (2020-2031)

3.4.3 North America Mirabegron Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Mirabegron Drugs Market Facts & Figures by Country

3.5.1 Europe Mirabegron Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Mirabegron Drugs Sales by Country (2020-2031)

3.5.3 Europe Mirabegron Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Mirabegron Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Mirabegron Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Mirabegron Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Mirabegron Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Mirabegron Drugs Market Facts & Figures by Country

3.7.1 Latin America Mirabegron Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Mirabegron Drugs Sales by Country (2020-2031)

3.7.3 Latin America Mirabegron Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Mirabegron Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Mirabegron Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Mirabegron Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Mirabegron Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Mirabegron Drugs Sales by Type (2020-2031)

4.1.1 Global Mirabegron Drugs Sales by Type (2020-2025)

4.1.2 Global Mirabegron Drugs Sales by Type (2026-2031)

4.1.3 Global Mirabegron Drugs Sales Market Share by Type (2020-2031)

4.2 Global Mirabegron Drugs Revenue by Type (2020-2031)

4.2.1 Global Mirabegron Drugs Revenue by Type (2020-2025)

4.2.2 Global Mirabegron Drugs Revenue by Type (2026-2031)

4.2.3 Global Mirabegron Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Mirabegron Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Mirabegron Drugs Sales by Application (2020-2031)

5.1.1 Global Mirabegron Drugs Sales by Application (2020-2025)

5.1.2 Global Mirabegron Drugs Sales by Application (2026-2031)

5.1.3 Global Mirabegron Drugs Sales Market Share by Application (2020-2031)

5.2 Global Mirabegron Drugs Revenue by Application (2020-2031)

5.2.1 Global Mirabegron Drugs Revenue by Application (2020-2025)

5.2.2 Global Mirabegron Drugs Revenue by Application (2026-2031)

5.2.3 Global Mirabegron Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Mirabegron Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Astellas Pharma

6.1.1 Astellas Pharma Company Information

6.1.2 Astellas Pharma Description and Business Overview

6.1.3 Astellas Pharma Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Astellas Pharma Mirabegron Drugs Product Portfolio

6.1.5 Astellas Pharma Recent Developments/Updates

6.2 Zydus Lifesciences

6.2.1 Zydus Lifesciences Company Information

6.2.2 Zydus Lifesciences Description and Business Overview

6.2.3 Zydus Lifesciences Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Zydus Lifesciences Mirabegron Drugs Product Portfolio

6.2.5 Zydus Lifesciences Recent Developments/Updates

6.3 Lupin Pharmaceuticals

6.3.1 Lupin Pharmaceuticals Company Information

6.3.2 Lupin Pharmaceuticals Description and Business Overview

6.3.3 Lupin Pharmaceuticals Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Lupin Pharmaceuticals Mirabegron Drugs Product Portfolio

6.3.5 Lupin Pharmaceuticals Recent Developments/Updates

6.4 Alkem Laboratories

6.4.1 Alkem Laboratories Company Information

6.4.2 Alkem Laboratories Description and Business Overview

6.4.3 Alkem Laboratories Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Alkem Laboratories Mirabegron Drugs Product Portfolio

6.4.5 Alkem Laboratories Recent Developments/Updates

6.5 Chia Tai Tianqing Pharmaceutical

6.5.1 Chia Tai Tianqing Pharmaceutical Company Information

6.5.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview

6.5.3 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product Portfolio

6.5.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

6.6 Zhejiang Huayi Pharmaceutical

6.6.1 Zhejiang Huayi Pharmaceutical Company Information

6.6.2 Zhejiang Huayi Pharmaceutical Description and Business Overview

6.6.3 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product Portfolio

6.6.5 Zhejiang Huayi Pharmaceutical Recent Developments/Updates

6.7 China Resources Pharmaceutical

6.7.1 China Resources Pharmaceutical Company Information

6.7.2 China Resources Pharmaceutical Description and Business Overview

6.7.3 China Resources Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 China Resources Pharmaceutical Mirabegron Drugs Product Portfolio

6.7.5 China Resources Pharmaceutical Recent Developments/Updates

6.8 Jiangxi Shanxiang Pharmaceutical

6.8.1 Jiangxi Shanxiang Pharmaceutical Company Information

6.8.2 Jiangxi Shanxiang Pharmaceutical Description and Business Overview

6.8.3 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product Portfolio

6.8.5 Jiangxi Shanxiang Pharmaceutical Recent Developments/Updates

6.9 CSPC Pharmaceutical

6.9.1 CSPC Pharmaceutical Company Information

6.9.2 CSPC Pharmaceutical Description and Business Overview

6.9.3 CSPC Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 CSPC Pharmaceutical Mirabegron Drugs Product Portfolio

6.9.5 CSPC Pharmaceutical Recent Developments/Updates

6.10 Qilu Pharmaceutical

6.10.1 Qilu Pharmaceutical Company Information

6.10.2 Qilu Pharmaceutical Description and Business Overview

6.10.3 Qilu Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Qilu Pharmaceutical Mirabegron Drugs Product Portfolio

6.10.5 Qilu Pharmaceutical Recent Developments/Updates

6.11 Jiangsu Huayang Pharmaceutical

6.11.1 Jiangsu Huayang Pharmaceutical Company Information

6.11.2 Jiangsu Huayang Pharmaceutical Description and Business Overview

6.11.3 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product Portfolio

6.11.5 Jiangsu Huayang Pharmaceutical Recent Developments/Updates

6.12 Sichuan Gowell Pharmaceutical

6.12.1 Sichuan Gowell Pharmaceutical Company Information

6.12.2 Sichuan Gowell Pharmaceutical Description and Business Overview

6.12.3 Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Sichuan Gowell Pharmaceutical Mirabegron Drugs Product Portfolio

6.12.5 Sichuan Gowell Pharmaceutical Recent Developments/Updates

6.13 Shenzhen Main Luck Pharmaceuticals

6.13.1 Shenzhen Main Luck Pharmaceuticals Company Information

6.13.2 Shenzhen Main Luck Pharmaceuticals Description and Business Overview

6.13.3 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product Portfolio

6.13.5 Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Mirabegron Drugs Industry Chain Analysis

7.2 Mirabegron Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Mirabegron Drugs Production Mode & Process Analysis

7.4 Mirabegron Drugs Sales and Marketing

7.4.1 Mirabegron Drugs Sales Channels

7.4.2 Mirabegron Drugs Distributors

7.5 Mirabegron Drugs Customer Analysis

8 Mirabegron Drugs Market Dynamics

8.1 Mirabegron Drugs Industry Trends

8.2 Mirabegron Drugs Market Drivers

8.3 Mirabegron Drugs Market Challenges

8.4 Mirabegron Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zydus Lifesciences

Lupin Pharmaceuticals

Alkem Laboratories

Chia Tai-Tianqing Pharmaceutical

Zhejiang Huayi Pharmaceutical

China Resources Pharmaceutical

Jiangxi Shanxiang Pharmaceutical

CSPC Pharmaceutical

Qilu Pharmaceutical

Jiangsu Huayang Pharmaceutical

Sichuan Gowell Pharmaceutical

Shenzhen Main Luck Pharmaceuticals

Astellas Pharma

List of Tables

Table 1. Global Mirabegron Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Mirabegron Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Mirabegron Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Mirabegron Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Mirabegron Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Mirabegron Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Mirabegron Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Mirabegron Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Mirabegron Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Mirabegron Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Mirabegron Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Mirabegron Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Mirabegron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mirabegron Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Mirabegron Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Mirabegron Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Mirabegron Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Mirabegron Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Mirabegron Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Mirabegron Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Mirabegron Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Mirabegron Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Mirabegron Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Mirabegron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Mirabegron Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Mirabegron Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Mirabegron Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Mirabegron Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Mirabegron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Mirabegron Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Mirabegron Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Mirabegron Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Mirabegron Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Mirabegron Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Mirabegron Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Mirabegron Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Mirabegron Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Mirabegron Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Mirabegron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Mirabegron Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Mirabegron Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Mirabegron Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Mirabegron Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Mirabegron Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Mirabegron Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Mirabegron Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Mirabegron Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Mirabegron Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Mirabegron Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Mirabegron Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Mirabegron Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Mirabegron Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Mirabegron Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Mirabegron Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Mirabegron Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Mirabegron Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Mirabegron Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Mirabegron Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Mirabegron Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Mirabegron Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Mirabegron Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Mirabegron Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Mirabegron Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Mirabegron Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Mirabegron Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Mirabegron Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Mirabegron Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Mirabegron Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Astellas Pharma Company Information

Table 71. Astellas Pharma Description and Business Overview

Table 72. Astellas Pharma Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Astellas Pharma Mirabegron Drugs Product

Table 74. Astellas Pharma Recent Developments/Updates

Table 75. Zydus Lifesciences Company Information

Table 76. Zydus Lifesciences Description and Business Overview

Table 77. Zydus Lifesciences Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Zydus Lifesciences Mirabegron Drugs Product

Table 79. Zydus Lifesciences Recent Developments/Updates

Table 80. Lupin Pharmaceuticals Company Information

Table 81. Lupin Pharmaceuticals Description and Business Overview

Table 82. Lupin Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Lupin Pharmaceuticals Mirabegron Drugs Product

Table 84. Lupin Pharmaceuticals Recent Developments/Updates

Table 85. Alkem Laboratories Company Information

Table 86. Alkem Laboratories Description and Business Overview

Table 87. Alkem Laboratories Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Alkem Laboratories Mirabegron Drugs Product

Table 89. Alkem Laboratories Recent Developments/Updates

Table 90. Chia Tai Tianqing Pharmaceutical Company Information

Table 91. Chia Tai Tianqing Pharmaceutical Description and Business Overview

Table 92. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Chia Tai Tianqing Pharmaceutical Mirabegron Drugs Product

Table 94. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates

Table 95. Zhejiang Huayi Pharmaceutical Company Information

Table 96. Zhejiang Huayi Pharmaceutical Description and Business Overview

Table 97. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Zhejiang Huayi Pharmaceutical Mirabegron Drugs Product

Table 99. Zhejiang Huayi Pharmaceutical Recent Developments/Updates

Table 100. China Resources Pharmaceutical Company Information

Table 101. China Resources Pharmaceutical Description and Business Overview

Table 102. China Resources Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. China Resources Pharmaceutical Mirabegron Drugs Product

Table 104. China Resources Pharmaceutical Recent Developments/Updates

Table 105. Jiangxi Shanxiang Pharmaceutical Company Information

Table 106. Jiangxi Shanxiang Pharmaceutical Description and Business Overview

Table 107. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Jiangxi Shanxiang Pharmaceutical Mirabegron Drugs Product

Table 109. Jiangxi Shanxiang Pharmaceutical Recent Developments/Updates

Table 110. CSPC Pharmaceutical Company Information

Table 111. CSPC Pharmaceutical Description and Business Overview

Table 112. CSPC Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. CSPC Pharmaceutical Mirabegron Drugs Product

Table 114. CSPC Pharmaceutical Recent Developments/Updates

Table 115. Qilu Pharmaceutical Company Information

Table 116. Qilu Pharmaceutical Description and Business Overview

Table 117. Qilu Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Qilu Pharmaceutical Mirabegron Drugs Product

Table 119. Qilu Pharmaceutical Recent Developments/Updates

Table 120. Jiangsu Huayang Pharmaceutical Company Information

Table 121. Jiangsu Huayang Pharmaceutical Description and Business Overview

Table 122. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Jiangsu Huayang Pharmaceutical Mirabegron Drugs Product

Table 124. Jiangsu Huayang Pharmaceutical Recent Developments/Updates

Table 125. Sichuan Gowell Pharmaceutical Company Information

Table 126. Sichuan Gowell Pharmaceutical Description and Business Overview

Table 127. Sichuan Gowell Pharmaceutical Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Sichuan Gowell Pharmaceutical Mirabegron Drugs Product

Table 129. Sichuan Gowell Pharmaceutical Recent Developments/Updates

Table 130. Shenzhen Main Luck Pharmaceuticals Company Information

Table 131. Shenzhen Main Luck Pharmaceuticals Description and Business Overview

Table 132. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Shenzhen Main Luck Pharmaceuticals Mirabegron Drugs Product

Table 134. Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Mirabegron Drugs Distributors List

Table 138. Mirabegron Drugs Customers List

Table 139. Mirabegron Drugs Market Trends

Table 140. Mirabegron Drugs Market Drivers

Table 141. Mirabegron Drugs Market Challenges

Table 142. Mirabegron Drugs Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Mirabegron Drugs

Figure 2. Global Mirabegron Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Mirabegron Drugs Market Share by Type: 2024 & 2031

Figure 4. Extended-release Tablet Product Picture

Figure 5. Oral Suspension Product Picture

Figure 6. Global Mirabegron Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Mirabegron Drugs Market Share by Application: 2024 & 2031

Figure 8. Urgency

Figure 9. Frequent Urination

Figure 10. Urine Leakage

Figure 11. Other

Figure 12. Global Mirabegron Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Mirabegron Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Mirabegron Drugs Sales (2020-2031) & (K Units)

Figure 15. Global Mirabegron Drugs Average Price (US$/Unit) & (2020-2031)

Figure 16. Mirabegron Drugs Report Years Considered

Figure 17. Mirabegron Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Mirabegron Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Mirabegron Drugs Players: Market Share by Revenue in Mirabegron Drugs in 2024

Figure 20. Mirabegron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Mirabegron Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Mirabegron Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Mirabegron Drugs Revenue Market Share by Country (2020-2031)

Figure 24. United States Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Mirabegron Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Mirabegron Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Mirabegron Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Mirabegron Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Mirabegron Drugs Sales Market Share by Country (2020-2031)

Figure 43. Latin America Mirabegron Drugs Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Mirabegron Drugs Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Mirabegron Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Mirabegron Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Mirabegron Drugs by Type (2020-2031)

Figure 54. Global Revenue Market Share of Mirabegron Drugs by Type (2020-2031)

Figure 55. Global Mirabegron Drugs Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Mirabegron Drugs by Application (2020-2031)

Figure 57. Global Revenue Market Share of Mirabegron Drugs by Application (2020-2031)

Figure 58. Global Mirabegron Drugs Price (US$/Unit) by Application (2020-2031)

Figure 59. Mirabegron Drugs Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions